Entries by Bastian Arlt

, ,

Cellulose CELLETS as new type of adsorbent for the removal of dyes from aqueous media

Abstract CELLETS, a new type of adsorbent, have emerged as a promising solution in water treatment. They are particularly effective in fixed-bed column systems for removing persistent organic pollutants, such as synthetic dyes. This summary reflects research published by Suteu et al. [1]. Fixed-bed adsorption is a well-established filtration method. It allows continuous treatment of […]

,

Renewable Resource Biosorbents: Granulated Cellulose CELLETS 200 for Organic Pollutants Adsorption in Fixed-Bed Column Systems

Introduction Fixed-bed column techniques are widely applied in water and wastewater treatment to achieve continuous adsorption of pollutants. In these systems, aqueous effluent flows through a packed bed of adsorbent material, offering operational simplicity, easy scale-up, and consistent performance—critical features in industrial and pharmaceutical settings. However, removing dyes from pharmaceutical effluents presents unique challenges: dyes […]

,

Fixed-bed-column studies for methylene blue removal by CELLETS

This study investigated fixed-bed columns for methylene blue removal. It evaluated CELLETS®, a granulated spherical cellulose material, as an adsorbent in the system [1]. CELLETS® 200 has useful properties, including perfect sphericity, narrow particle size distribution, low friability, and chemical inertness. Experiments used a dye solution (9–10 mg/L, pH 4.7) with different flow rates. We […]

Ultrasound Imaging of Artificial Tongues – an approach with Cellets

The article titled “Ultrasound Imaging of Artificial Tongues During Compression and Shearing of Food Gels on a Biomimetic Testing Bench” by Glumac et al. [1] introduces a novel method to study tongue–food interactions using ultrasound (US) imaging. The study primarily aims to improve understanding of mechanical processes during oral food processing. In particular, it focuses on […]

Patent on solid oral dosage form comprising antibodies for sustained release in the lower gastrointestinal tract

Abstract The patent “Solid oral dosage form comprising antibodies for sustained release in the lower gastrointestinal tract” (US20250127722A1 [1]) presents a novel pharmaceutical formulation. It uses microcrystalline cellulose pellets, called CELLETS®, as inert starter cores for controlled-release drug delivery systems. Moreover, these CELLETS® act as a stable foundation, ensuring uniform layering of active pharmaceutical ingredients […]

, ,

Real-time monitoring of multiparticulate coating processes at industrial-scale using ultra-high-resolution optical coherence tomography

Real-time monitoring of multiparticulate coating processes at industrial-scale is a critical demand for continuous and batch-wise process technologies. A combination with ultra-high-resolution optical coherence tomography is indeed a brilliant idea. Results were recently published by Wolfgang et al. [1] Previous challenges in PAT of multiparticulate systems This study presents a significant advancement in pharmaceutical process […]

,

Patent on oral formulations of a Pyridinone derivate

Abstract This patent describes an oral formulation designed to deliver a drug (a Pyridinone derivative) specifically to the small intestine. The formulation contains coated granules, pellets, beads, minicapsules, or minitablets. Each particle includes a core material and an enteric coating polymer, which ensures targeted drug release. Moreover, the patent covers the preparation method and its […]